Home > Financial Ratios > ALKEM LABORATORIES

ALKEM LABORATORIES
Core EBITDA Growth

    Back to All Ratios
ALKEM LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ALKEM LABORATORIES
Please provide your vote to see the results

ALKEM LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.5940.03-17.601.8437.90

What is the latest Core EBITDA Growth ratio of ALKEM LABORATORIES ?

The latest Core EBITDA Growth ratio of ALKEM LABORATORIES is 17.59 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.59
Mar202440.03
Mar2023-17.60
Mar20221.84
Mar202137.90

How is Core EBITDA Growth of ALKEM LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 17.59
-56.06
Mar2024 40.03
Positive
Mar2023 -17.6
Negative
Mar2022 1.84
-95.15
Mar2021 37.9 -

Other Financial Ratios of ALKEM LABORATORIES


Compare Core EBITDA Growth ratio of peers of ALKEM LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALKEM LABORATORIES ₹64,182.1 Cr 0.3% -2.4% 10.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,104.0 Cr 3.5% -1.5% 9% Stock Analytics
DIVIS LABORATORIES ₹180,119.0 Cr 1.1% -1.1% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,871.0 Cr -0.2% -0.3% 35% Stock Analytics
CIPLA ₹114,334.0 Cr 3.1% 1% -11.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,761.0 Cr 1.1% -2.1% -5.6% Stock Analytics


ALKEM LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALKEM LABORATORIES

0.3%

-2.4%

10.4%

SENSEX

1.1%

2.4%

-5%


You may also like the below Video Courses